lapatinib i.p. 250 mg
NEOLAPA 250MG is a prescription anti-cancer medication containing Lapatinib (250 mg), primarily used to treat advanced or metastatic HER2-positive breast cancer.
Click to expand
Anti Cancer Tablets
lapatinib i.p. 250 mg
By Neon Laboratories Ltd
Our Price
₹9,135WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
250 MG
Packaging
BOTTLE OF 30 TABS
Type
Bottle
Shelf Life
24 months (2 years).
NEOLAPA 250MG is a prescription anti-cancer medication containing Lapatinib (250 mg), primarily used to treat advanced or metastatic HER2-positive breast cancer.
Manufacturer Info
NameNeon Laboratories Ltd
PrescriptionPrescription
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.
LAPATINIB I.P. 250 MG
₹9,135